BUD vs STZ: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
BUD is the larger of the two ($158.18B market cap): the incumbent the market prices for continued execution (16.46x forward earnings, beta 0.74). STZ is the smaller challenger ($24.45B), cheaper on forward earnings (11.93x): more room to run, but more to prove. If you believe BUD earns its premium (16.46x forward earnings, so the market expects more from it), BUD fits. If you believe in paying less for profit, STZ fits at 11.93x.
BUD vs STZ: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | BUD | STZ | What it tells you |
|---|---|---|---|
| Market cap | $158.18B | $24.45B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 16.46 | 11.93 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 16.33 | 12.94 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.74 | 0.40 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 77% of range | 58% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 10.14 | 2.86 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: STZ is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how BUD and STZ affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BUD and STZ share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BUD and STZ exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Anheuser-Busch InBev SA/NV (BUD) do?
Anheuser-Busch InBev SA/NV is the largest beer company in the world, formed through a series of mega-mergers that combined Anheuser-Busch, InBev, and SABMiller. It is headquartered in Leuven, Belgium, and its US-listed shares trade as an American Depositary Receipt (ADR) under the ticker BUD, so US investors own a receipt representing the underlying foreign shares. Its portfolio spans global brands such as Budweiser, Corona, and Stella Artois, alongside Michelob Ultra and a wide set of local champion brands that lead individual markets across Latin America, Africa, and Asia Pacific.
What does Constellation Brands (STZ) do?
Constellation Brands is a producer, marketer, and distributor of beer, wine, and spirits, best known for holding the US rights to Mexican import beers including Corona, Modelo Especial, and Pacifico. Beer is the economic engine: it drives the large majority of both net sales and operating income, and Modelo Especial has been one of the top-selling beer brands in the US. The wine and spirits segment is far smaller and has been contracting, partly by design after the company divested lower-priced wine brands (including SVEDKA and a 2025 wine portfolio sale) to concentrate on higher-margin labels.
BUD vs STZ: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- BUD drivers: Premiumization and pricing power; Deleveraging the balance sheet.
- STZ drivers: Imported beer franchise; Cash generation and buybacks.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The clearest risk is the debt load itself: while falling, it remains large (about $72.7 billion of total debt at the latest balance sheet), and slow deleveraging or higher interest rates would keep pressure on the stock. For STZ, the largest risk is US tariffs on Mexican imports: because the bulk of Constellation's beer is brewed in Mexico, tariff changes can meaningfully pressure margins and earnings, and management has flagged a potential multi-dollar per-share EPS headwind.
BUD or STZ: which should you pick?
If the story you believe is BUD's (Premiumization and pricing power), BUD is the more direct way to own it; if it is STZ's (Imported beer franchise), STZ is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BUD and STZ guides.
BUD vs STZ: the full fundamentals
BUD. Figures are approximate, from Yahoo Finance data as of November 20, 2026. After a 26% rise this year the ADR trades near 16 times earnings, closer to other large staples than the discount it carried while leverage was higher, and analysts' average target sits near $95 across 11 analysts. The valuation debate still centers on the pace of debt reduction and on currency: as an ADR, reported results and the dividend are translated from foreign currencies, so a strong US dollar can dampen returns for US holders.
STZ. As of November 20, 2026 STZ traded at about $144.81, about 13x trailing earnings, up from about 11.7x in mid-October but still beneath its multi-year historical range, with tariff concerns and a flat US beer market weighing on the multiple. Reported net income can be distorted in periods with large non-cash wine and spirits impairments, so free cash flow (about $1.12 billion trailing) is often a cleaner read on the business. The next report, for fiscal Q3 2027, is expected around January 7, 2027, with consensus EPS of about $2.73 on about $2.19 billion of revenue.
Headline figures (approximate, November 2026): BUD shows revenue (ttm) ~$64.0 billion; latest quarter up ~9% year over year, latest quarter (q3 2026) Revenue ~$16.5 billion, net income ~$1.6 billion, EPS $1.21 vs ~$1.17 expected, net income (ttm) ~$9.9 billion; operating margin ~27%, profit margin ~15%, p/e ~16.3x trailing, ~16.5x forward; STZ shows revenue (ttm) ~$9.2B (latest quarter up ~6% YoY), fiscal q2 2027 comparable eps $3.74 vs $3.55 est., margins (ttm) ~53% gross, ~33% operating, ~21% net, net income (ttm) ~$1.9B.
The bottom line: BUD vs STZ
BUD and STZ are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined BUD and STZ exposure against your real portfolio. It is not an investment adviser.
Wondering how BUD or STZ fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Anheuser-Busch InBev SA/NV
Ask Walnut's AI anything about BUD and see how it fits what you own.
FAQ
What is the difference between BUD and STZ?
+
Anheuser-Busch InBev SA/NV is the largest beer company in the world, formed through a series of mega-mergers that combined Anheuser-Busch, InBev, and SABMiller. Constellation Brands is a producer, marketer, and distributor of beer, wine, and spirits, best known for holding the US rights to Mexican import beers including Corona, Modelo Especial, and Pacifico. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is BUD or STZ the better stock?
+
Neither is universally better. BUD is the larger incumbent; STZ is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, BUD or STZ?
+
On forward P/E (as of November 2026), BUD trades at 16.46x and STZ at 11.93x, so STZ is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both BUD and STZ?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of BUD vs STZ?
+
BUD: The clearest risk is the debt load itself: while falling, it remains large (about $72.7 billion of total debt at the latest balance sheet), and slow deleveraging or higher interest rates would keep pressure on the stock. As an ADR of a Belgium-based company that earns across many currencies, BUD carries currency risk, and a strong US dollar can reduce reported results and the value of foreign earnings for US holders. Volume growth is structurally slow in developed markets, and beer faces long-run competition from wine, spirits, cannabis, and a broader moderation-in-drinking trend among younger consumers. In the United States, the company is still recovering from the 2023 Bud Light boycott, which dented its mainstream domestic share. Emerging-market exposure adds economic and political volatility, and input-cost and tariff swings can pressure margins. After a 26% gain this year, and with analysts expecting 2027 EPS of about $4.88, slightly below trailing EPS of about $4.92, the valuation also leaves less room for a disappointing quarter. Because so much of the thesis rests on deleveraging, any setback to free cash flow directly threatens the core investment case. STZ: The largest risk is US tariffs on Mexican imports: because the bulk of Constellation's beer is brewed in Mexico, tariff changes can meaningfully pressure margins and earnings, and management has flagged a potential multi-dollar per-share EPS headwind. Softer spending by lower-income and Hispanic consumers, who are an important beer demographic, can slow depletions. The wine and spirits segment continues to shrink and has taken large non-cash goodwill impairments. The dividend payout ratio has at times exceeded reported net income (inflated by impairments), so the dividend leans on free cash flow rather than accounting earnings. US beer volumes have been stagnant, and analysts expect fiscal Q3 2027 EPS of about $2.73, down about 11% year over year, and full fiscal 2027 EPS of about $11.82, roughly flat. Debt is about $10.3 billion against under $100 million of cash. Broader risks include input-cost inflation, foreign-exchange swings in the Mexican peso, and shifting alcohol-consumption trends among younger consumers.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell BUD or STZ; figures are approximate and dated (as of November 2026). Verify current data before investing.